| Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company focused on developing, manufacturing, marketing and distributing pharmaceutical products. Co.'s segments are: Generics, which includes product families covering a range of dosage forms and delivery systems, including both immediate and extended release oral solids, powders, liquids, inhalation and respiratory products, ophthalmics, films, transdermal patches and topicals; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products; and AvKARE, which provides pharmaceuticals, medical and surgical products and services. We show 16 historical shares outstanding datapoints in our AMRX shares outstanding history coverage, used to compute AMRX market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AMRX market cap history over the course of time is important for investors
interested in comparing AMRX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AMRX versus a peer is one thing; comparing
AMRX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AMRX can fluctuate over the course of history.
With this page we aim to empower investors researching AMRX by allowing them to research the AMRX market cap history.